Printer Friendly

The best heavy metal chelator: rise ... for sentencing.

With scientific studies continuing to detect an alarming consistency of a heavy metal presence within modern human populations, the subject of an effective treatment for heavy metal toxicity has received a corresponding spotlight, especially in alternative medicine media. The heavy metal agents--cadmium, lead, mercury, and others--possess practically unlimited morbidity for any organ and tissue, including carcinogenicity and geno- and feto-toxicity. Human exposure to these potent toxicants has been detected early in life--at the time of delivery (in cord blood) and in mother's breast milk--and in remote areas as far away as the Arctic, thanks to industrial activity, which is turning the oceans and skies into virtual toxic dumpsters.

In light of these troubling findings, the issue of elimination of heavy metals via chelating-binding agents has also become a prime clinical, therapeutic, and economic topic. Chelators of all makes and shapes--herbal, mineral, nutritional, algae type, megadose vitamin C infusions, drugs (DMSA, DMPS, EDTA), and others, or combinations thereof--have been proposed as solutions. Even homeopathic formulas have been put together to join the race. Most of these are prompted to health practitioners and directly to "the customer"--the public--for a "do it yourself job." Recently, I came across another marketed "natural" chelator, a hybrid of several agents, joining the "choir" as yet another treatment allegedly superior to the rest. This treatment even was "proven," so states the inventor, through nothing less than a clinical double-bind placebo controlled study! Considering the fine print in the text indicating that "most" of the substances were double-blinded and also noting that the study was not scrutinized by a peer-review journal leaves room for doubts, especially considering overall concerns about chelation self-treatments, in the extensive experience of this author.

If one plays "devil's advocate" first and anticipates all possible and legitimate reasons on the part of the chelation premise, one can certainly view the idea itself of using toxin-binding agents as quite plausible. Yet a counter question arises: is the mere presence of therapeutic plausibility sufficient? If that's the case, then by the prevailing tenets of scientific deductive reasoning and rules, other examples from medical practice concerning a plausibility issue cannot conflict with the phenomenon. However, quite commonly, just the opposite has been observed. Here are just a few examples: chemotherapy for cancers; anti-inflammatory and immunosuppressive agents for autoimmune and inflammatory diseases; antibiotics against chronic Lyme disease; or childhood vaccines for preventative purposes. On the surface, all enjoy a truly sound premise. Yet, what has often occurred in reality has been that the treatments themselves have produced a far greater morbidity than the conditions they attempted to remedy or prevent. So, from this illustration, one is compelled to conclude that the plausibility factor alone, albeit necessary, is unfortunately insufficient.

Another potentially misleading notion arising from the "makes sense" plausibility factor is that most tend to equate therapeutic chelation of heavy metals with an automatic and unavoidable elimination from the body. However, what I have observed in practice on hundreds of patients is that actual outcomes are much further from fulfilling these criteria than we all would like to believe. The first in a long row of these observations occurred many years ago when I used intravenous EDTA chelation therapy not only for cardio- and other vascular diseases, but also to eliminate mercury in chronically ill patients. Unlike the great majority of cardiovascular patients--usually fairly husky men tolerating the procedure well--chronic patients, with a variety of ailments, consistently complained of feeling "washed out," a feeling that often persisted long past the day of therapy or diagnositc/provocation test. The doses administered were not excessive. One case finally drove the point deep enough into my brain to register: a robust-looking, but frail police detective returned a month after a chelating session for mercury toxicity only to report that, for the whole month, he had remained sleepless while sensing an impending breakdown as a result. A case of therapy-caused iatrogenicity was obvious and so was the fact that a redistribution of mercury into the patient's brain took place in the process, instead of the mercury's expected elimination.

One should keep in mind that EDTA is not considered a potent mercury chelator, per se, and in the case of this patient, the finding was deemed to be even more bothersome. At that time, my concurrent experiments using mercury chelators DMPS or DMSA, highly touted as "strong" for diagnostic provocation or therapeutic purposes, yielded equally disturbing outcomes in the greater number of patients. I have seen many patients whom have abandoned similar procedures elsewhere and confirmed what was becoming evident: that chelators, along with a partial excretion, do concurrently lead to an uncontrolled redistribution of heavy metals in the body. Homeopathic compounds, which act via other mechanisms--i.e., the body's stimulation vs. chelation itself--are no better in terms of safety and redistribution control. And the stronger the chelator--natural or synthetic--the greater the risk.

Summarizing the nature of the process briefly, the chelators--parenteral or oral--mobilize the organ's tissue's dormant metals and dump them into systemic circulation. From there, instead of following the textbook-designated route--exiting the body via excretory pathways such as kidneys, colon, lungs, and skin--they follow this route only partially and tend to redistribute metals throughout the body, redepositing them either into the same or different organs and tissues. These parts, being overtly or latently weak, often become the first victims, leading to both short- and/or long-term morbidity. When chelating physicians or chelating product manufacturers have no control over this process, more hierarchically vital organs and structures in the body (than those where an actual mobilization has taken place) may become "hit." For example, a redistribution of heavy metals from fat, muscles, skin, and other tissues of lower physiologic hierarchy than brain structures, bone marrow, adrenal glands, spinal cord, or heart arteries may have caused very serious complications in many cases that I happened to evaluate. That is why many patients, particularly those who have been treated or diagnostically "provoked" with mercury chelators, often complain of severe fatigue, brain fog, headaches, visual disturbances, and a variety of other somatic problems. Besides these, an overload of the excretory organs themselves often also takes place, particularly within the kidneys, the true functional state of which remains largely unknown, in spite of the "normal" baseline or ongoing lab tests.

Certainly there is a group, a definite minority in my observations, who has claimed clinical improvement from heavy metal chelators. This, per se, does not conflict with the agenda of caution emphasized here, since from the knowledge of classical homeopathy or Chinese medicine, we know that there are individuals who are constitutionally more robust than others (including their excretory organs) and who, therefore, can handle the chelating process better. Yet, even in this more robust group, following numerous chelating procedures elsewhere, bioresonance testing has invariably found heavy metals, with mercury as the leader, still in many organs. Another under-publicized limitation of chelators is their apparent inability, in large part due to the aforementioned reasons, to completely remove metals. This can be because their penetrating ability into certain organs and tissues (due to individual anatomical composition) can be suboptimal in relation to other organs.

Moreover, concurrent interaction of the mobilized metals during chelation with abundant electromagnetic fields in our environment will greatly augment the unpredictability factor concerning the ultimate disposal of metals, and instead of the hopped-for "out the door" straight excretion path, this often leads to their organ-to-organ zigzagging and to outright excretory blocks.

There is also a misnomer concerning heavy metal removal that needs to be challenged, especially against the background of chelators' marketing war and corresponding unwarranted claims. I refer to the tendency of portraying some natural and non-drug chelators as "better" ones. As the market keeps spewing more and more exotic compounds (and I predict that something like a "patented" cosmic dust or ground-up meteorite will be the next in line for the job), a word of caution has been overdue. The main problem with these claims, in my opinion, isn't the fact that they are false, but that they are true, indeed. All or just about all of these are capable of the mobilization of metals. However, it has to be obvious that if we dare to tamper with the pile of explosives (that is how toxic metals should be viewed), regardless of the nature of the first step, the rest of the process better be tightly and properly safeguarded--or else.

To illustrate this very important clinical point, why don't we take lessons from well-known environmental interventions aimed at the removal of asbestos or paint containing lead or mercury? A whole chain of necessary tedious measures is undertaken to protect the immediate environment during the removal process, whether this takes place in the basement, hallway, or kitchen. Surprisingly, therapeutic procedures with similar aims do next to nothing to affect the movement of internal toxins. One has to ask why they don't work to protect the body on the inside when these reactions may affect the heart, brain, or immune system.

Beside observing the real action of these material products numerous times on others, I can offer an example from my own personal "guinea pig" experience of bioresonance testing (BRT) via an electroacupuncture according to Voll (EAV) device many years ago. Lead was correctly identified as the culprit, and a homeopathic treatment, according to the "know-it-all"--our cultural god, the computer--followed. The end result was that I found myself walking vigorously the next morning, but on my hands with my feet facing the ceiling, toward my medicine cabinet to dig out the correct kidney remedy to end the agony of paralyzing kidney pain. The weak chelators aren't necessarily safe either, since a chelator doesn't just work by itself or with a piece of metal, but within an individual human body endowed with its own and already preexisting strengths and weaknesses, including those of the excretory organs.

On this note, I have to mention that, unfortunately, I've tested and observed many autistic and ADHD children subjected widely to chelating agents by autism "specialists." It is also worth mentioning that while the great majority of chelators are not capable of penetrating the blood-brain barrier, the stirred-up metals do penetrate it at-will, leading potentially to a precarious situation with a one-way valve--in the wrong direction.

The generic concept of detox-provoked and lasting aggravations isn't new in and of itself, and some companies in Germany and Europe, in general, have attempted to ease it via certain homeopathic or herbal treatments or a combination thereof--"i.e., drainage remedies." The idea was hastily copied in North America. Unfortunately, I have found these products also to be very nonspecific, since the presence of many homeopathic constituents (belonging to deep-acting constitutional remedies) also is prone to stirring up even deeper toxic releases. The end result, particularly with weak patients, is a true detoxifying chaos and a "patch up job."

It seemed obvious from these experiences that two crucial components were necessary in order to assure a successful and safe metal elimination process:

1. A diagnostic tool able to tune in and monitor every single stressed and/or weak organ and tissue in the body and also to determine the presence of metals and a functional status of the excretory organs

No diagnostic test is capable of accomplishing this--except for BRT. BRT has to be carried out prior to and following each therapeutic metal-removal process and, if necessary, even during the process. There are many hurdles in the ability to identify metals at multiple levels in a single organ or tissue that many bioresonance testing practitioners have yet to overcome. The deficiency does lead to severe therapeutic aggravations.

2. The therapy must induce not only the release of metals but must also concurrently support every weak or stressed organ, particularly excretory functions, as identified via. BRT. Only homeopathic remedies are capable of such a specific organ action, but the new homeopathic system had to and has evolved, through the author's experience, to accomplish this. The system has endured years of testing and on the sickest and weakest chronically ill, too.

A brief note concerning intravenous EDTA chelation therapy. Even though, through the experience of my homeopathic system and therapy, I have found homeopathics to be more effective than EDTA infusions in the treatment of cardiovascular diseases, I have also found intravenous EDTA, on the whole, quite effective and safe in treating the great majority of patients with degenerative vascular diseases. In my experience, since heavy metals play a primary role in all chronic diseases--and vascular diseases, in particular--I wish to share just a few documented recovery cases through the bio-energetic diagnostic/therapeutic system that I advocate.

Case #1-Patient J.C.

A 43 y.o. man with typical angina pectoris

SPECT: Stress test and gaited spect; March 1997

Impression: Minimal exercise-induced ischemia, involving the antero-lateral walls of the left ventricle

Follow-up study; December 1997: Impression: Normal myocardial perfusion scan; no evidence of ischemia or infarction

Case #2--Patient J.E.

A 38 y.o. man after myocardial infarction in December 2002, with continuing unstable angina pectoris

SPECT: Myocardial Perfusion Imaging; January 2003

The exercise stress was stopped, due to chest pain, shortness of breath, diaphoresis, and dizziness; exercise capacity--5 METS (low)

SPECT Imaging demonstrated:

1. Mild ischemia involving the basal interior wall

2. Small infarction involving the apex

3. Normal size left ventricle and ejection fraction

Follow-up study; December 2003: Exercise stress test asymptomatic at the 90% of maximum predicted heart rate; exercise capacity--7 METS (moderare)

SPECT Imaging:

1. No evidence of any significant fixed or reversible perfusion abnormality to suggest the presence of an infarct/scar or ischemia

2. Normal wall motion and ejection fraction

It is of interest that due to severe workload at this period, the patient indulged in compulsive binging, ballooning 100 lbs. in weight and raising his cholesterol.

Case #3--Patient E.R.

A 54 y.o. man with severe idiopathic cardiomyopathy, congestive heart failure, and dyspnea on mild exertion; 25-year Hx of hypertension.

Study: 2-D, M-mode ECHO (ultrasound) and color flow Doppler; January 1998


1. Akinetic anterior septal left ventricular wall extending into the left ventricular apex

2. Markedly hypokinetic remaining left ventricular walls

3. Marked left ventricular enlargement

4. Mitral regurgitation 1-2 +

5. Aortic regurgitation 1-2 +

6. Tricuspid regurgitation 1-2 +

7. Markedly depressed ejection fraction at 10%.

The patient was placed on a heart transplant waiting list.

Gated cardiac blood pool study; May 1998

Conclusion: Calculated ejection fraction is mildly diminished at 45.5%. There is a degree of hypokinesis in the apex.

The patient came off the list and discontinued all heart and blood pressure drugs.

Case #4--Patient D.D.

Winter 2007

A middle-aged man on high does thyroid as well as DHEA and testosterone hormone replacement medications due to the corresponding low laboratory values detected by his alternative MD

BRT: Mercury and lead residing in these and other organs

Treated accordingly with organ-tissue focused homeopathic system

Follow-up: Discontinued all hormones with the lab tests confirming corresponding restoration; he and his alternative MD were both surprised at a rapid concurrent drop in his urine mercury levels following DMPS provocation tests.


We should all be reminded periodically--adding to the famous admonition by the great Paracelsus that the dose, not the substance, deems a treatment either remedy or poison--that with few exceptions, a generic (mis)match between the product and disease factor or entity is no substitute for a strictly individualized approach to each individual patient. Furthermore, the good old principle "Physician, do no harm" remains just as sound. It is also my aspiration that the many chelating physicians and alternative professional organizations, including the ones that provide chelation training, will finally take heed to this sound premise.

Note from the author: This is an opinion article, and I enthusiastically invite any sound contradictory arguments.

For training information, please contact:

"SYY Integrated Health Systems, Ltd."


Fax: 914-861-9160

by Savely Yurkovsky, MD

Savely Yurkovsky, MD, offers complete training in the treatment of degenerative diseases through his novel approach: FCT-Field Control Therapy[R] or Guided Digital Medicine[TM], which transcends boundaries and limitations of medical specialties. Dr. Yurkovsky is internationally known as an author and teacher with an extensive background in the thorough study of scientific principles behind numerous alternative and conventional approaches.


Having evolved a unique bio-energetic medical system that integrates a great deal of pertinent but underused knowledge from medical and non-medical science, he has been able to transform the often vague nature of medical specialties from "hit and miss" paradigms into a far more effective, exact, and predictable science. He has founded a teaching organization, "SYY Integrated Health Systems, Ltd.," which is dedicated to sharing this medical system. This system has been presented at many professional symposia, including the annual Bio-terrorism 2005 Conference: "Unified Science & Technology for Reducing Biological Threats & Countering Terrorism" with affiliation to the Homeland Security Office and Harvard Medical School. Along with several other doctors from premier medical schools in the US, he has been nominated for the prestigious Bravewell Leadership Award for "significant contributions to the field of medicine" and "compelling vision for the future of medicine."
COPYRIGHT 2009 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Yurkovsky, Savely
Publication:Townsend Letter
Geographic Code:1USA
Date:Jan 1, 2009
Previous Article:The role of the clinical laboratory in Integrative and Functional Medicine.
Next Article:Inhalation insulin and oral and nasal insulin sprays for diabetics: panacea or evolving future health disaster part 2.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |